Healthconn Corp. (TPEX:6665)
Taiwan · Delayed Price · Currency is TWD 19.65
+0.35 (1.81%)
Jul 15, 2026, 12:54 PM CST
Healthconn Market Cap
Healthconn has a market cap or net worth of 875.26 million as of July 14, 2026. Its market cap has decreased by -23.26% in one year.
Market Cap
875.26M
Enterprise Value
756.03M
Revenue
1.13B
Ranking
n/a
PE Ratio
104.27
Stock Price
19.65
Market Cap Chart
Since November 23, 2017, Healthconn's market cap has decreased from 8.08B to 875.26M, a decrease of -89.17%. That is a compound annual growth rate of -22.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 911.54M | 0.25% |
| Dec 31, 2025 | 909.27M | 8.97% |
| Dec 31, 2024 | 834.44M | -35.44% |
| Dec 29, 2023 | 1.29B | -18.45% |
| Dec 30, 2022 | 1.58B | -26.87% |
| Dec 30, 2021 | 2.17B | -5.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 529.73B |
| Caliway Biopharmaceuticals | 167.31B |
| Heron Neutron Medical | 68.67B |
| Pell Bio-Med Technology | 59.93B |
| Perfect Medical Industry | 1.01B |
| U-Neuron Biomedical | 997.31M |
| GeneReach Biotechnology | 979.88M |
| TCI GENE | 978.96M |